Interested in learning more about Orca Bio’s investigational high-precision cell therapies? We partnered with The EBMT on a video that highlights the significant unmet need that exists for patients with #bloodcancer today, Orca Bio’s unique approach, and the potential for our investigational products to change the treatment paradigm. You can check out the video here: https://bit.ly/3Jku5GE #EBMT24 #bloodcancer #AML #oncology #leukemia
Orca Bio
Pharmaceutical Manufacturing
Menlo Park, CA 12,490 followers
Transforming allogeneic cell therapy for patients with blood cancer, genetic diseases and autoimmune disorders.
About us
Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patients’ diseased blood and immune system with a healthy one. Our manufacturing platform sorts donor blood with single-cell precision and a high level of purity and speed, enabling us to create proprietary, optimal therapeutic mixtures of immune and stem cells that have the potential to transform allogeneic cell therapy. Our talented team is driven by a passion for science and compassion for patients.
- Website
-
http://www.orcabio.com/
External link for Orca Bio
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Menlo Park, CA
- Type
- Privately Held
- Founded
- 2016
Locations
-
Primary
3475 Edison Way, Suite B
Menlo Park, CA 94025, US
-
3400 Business Dr
140
Sacramento, California 95820, US
Employees at Orca Bio
Updates
-
The Leukemia & Lymphoma Society recently asked how survivors of #bloodcancer would sum up their experience in just six words – and the responses are both inspiring and empowering. At Orca Bio, we are on a mission to ensure there are more survivors from blood cancers like #AML, #MDS and #ALL. To learn more: https://bit.ly/3W04Xe5
When you hear - “you have cancer” - life changes. #BloodCancer survivors summed up their lives as survivors in just six words. What are your six words? __ __ __ __ __ __ At every stage of your survivorship experience, we’ve got resources and information to help 👉 https://bit.ly/4eICTob
-
#ICYMI, Dr. Rawan Faramand of Moffit Cancer Center presented encouraging clinical data on our lead investigational T-cell immunotherapy, Orca-T, at #ASCO24. Speaking to CGTLive, Dr. Faramand described Orca-T’s potential to transform care for patients with acute myeloid leukemia, or #AML. Check out the video interview: https://bit.ly/3REh6UM #bloodcancer #AML #oncology #leukemia #celltherapy
-
Meet Adams Hendrickson, Associate Director of Finance and Operations on #TeamOrcaBio and this month’s #employeespotlight. Adams oversees the financial planning & analysis, contracting and procurement functions at Orca Bio. Adams is a California native and has spent his career working in the pharmaceutical industry at companies such as BioMarin, Medivation and Astex Pharmaceuticals. Prior to joining Orca Bio, Adams earned an MBA from the Haas School of Business at the University of California, Berkeley. Learn more about our exceptional team: https://bit.ly/3Rfnx0e
-
Today, we commemorate #Juneteenth, the United States’ second independence day. At Orca Bio we reflect on and celebrate this monumental day and significant milestone in the fight for freedom. Join us in learning more: https://s.si.edu/4aHg7K0
-
Join us in welcoming Katie Chaddock to the Orca Bio team as Site Head, Commercial Manufacturing. Katie brings over 25 years of experience manufacturing and supplying high quality pharmaceutical products to patients in need, most recently as Johnson & Johnson’s Head of Competitiveness, Autologous Therapies. Katie’s work has spanned many areas including generic medications, rare disease therapies and a pandemic fighting Covid vaccine. We’re thrilled to have you, Katie! #TeamOrcaBio #celltherapy #oncology
-
Join us in celebrating #PrideMonth! We proudly support the LGBTQ+ community and are committed to supporting an inclusive and equitable environment. Here at Orca Bio, fostering a sense of belonging on our team enhances each and every individual’s experience as we work toward our mission to change the lives of patients through novel cell therapies.
-
We’re pleased to announce the completion of enrollment in Precision-T, the pivotal Phase 3 study of our lead investigational allogeneic T-cell immunotherapy, Orca-T. To learn more: https://bit.ly/3X7Og2E #bloodcancer #AML #oncology #leukemia #celltherapy
-
We’re in San Diego for #BIO2024! Don’t miss Orca Bio Chief Commercial Officer Dan Kirby present our latest advances and vision for the future of cell therapy for patients with cancer, autoimmune diseases and genetic blood disorders. Check out our presentation details: https://bit.ly/3R4BT3q #bloodcancer #AML #oncology #leukemia #celltherapy